Assessing changes in ages at onset over successive generation: An application to breast cancer
Corresponding Author
Li Hsu
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., MW-805, P.O. Box 19024, Seattle, WA 98109-1024===Search for more papers by this authorLue Ping Zhao
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
Search for more papers by this authorKathleen E. Malone
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
Search for more papers by this authorJanet R. Daling
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
Search for more papers by this authorCorresponding Author
Li Hsu
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., MW-805, P.O. Box 19024, Seattle, WA 98109-1024===Search for more papers by this authorLue Ping Zhao
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
Search for more papers by this authorKathleen E. Malone
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
Search for more papers by this authorJanet R. Daling
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
Search for more papers by this authorAbstract
Decreased age at onset in successive generations has been observed for a number of diseases. Two nonparametric matched and unmatched test statistics are proposed, taking into account not only current age or age at death for unaffected individuals and age at disease onset for affected individuals, but also possible correlations among family members. Both are asymptotically normal with readily estimated variances from the data. A simulation study is conducted to compare the proposed tests with the commonly used paired t-test and log-rank test. It has been shown that the proposed test statistics yield valid conclusions in assessing genetic anticipation under all situations considered. However, the paired t-test is valid only when the censoring distributions are comparable between two generations, whereas the log-rank test is valid when the correlation among family members is weak. As expected, the matched test is most powerful when the data are heterogeneous, and the unmatched and the log-rank tests are most powerful when the data are homogeneous and the correlation is weak. Lastly, a population-based family study of breast cancer conducted at the Fred Hutchinson Cancer Research Center is used for illustration of the proposed and the log-rank tests. The preliminary analysis suggests that there appears a decreased age at onset over the successive generations in breast cancer. Genet. Epidemiol. 18:17–32, 2000. © 2000 Wiley-Liss, Inc.
REFERENCES
- Bowen T, Guy C, Speight G, Jones L, Cardno A, Murphy K, McGuffin P, et al. 1996. Expansion of 50 CAG/CTG repeats excluded in schizophrenia by application of a highly efficient approach using repeat expansion detection and a PCR screening set. Am J Hum Genet 59: 912–917.
- Chang-Claude J, Becher H, Eby N, Bastert G, Wahrendorf J, Hamann U. 1997. Modifying effect of reproductive risk factors on the age at onset of breast cancer for German BRAC1 mutation carriers. J Cancer Res Clin Oncol 123: 272–279.
- Cox DR. 1972. Regression models and life tables (with discussion). J Roy Statist Soc Series B 34: 187–200.
10.1111/j.2517-6161.1972.tb00899.x Google Scholar
- Deighton C, Heslop P, McDonagh J, Walker D, Thomson G. 1994. Does genetic anticipation occur in familial rheumatoid arthritis? Ann Rheum Dis 53: 833–835.
- Dieckmann KP, Klan R, Bunte S. 1993. HLA antigens, Lewis antigens, and blood groups in patients with testicular germ-cell tumors. Oncology 50: 252–258.
- Fleming TR, Harrington DP. 1991. Counting processes and survival analysis. New York: John Wiley & Sons.
- Ford D, Easton DF, Stratton M, Marod S, Goldgar D, Devilee P, Bishop DT, Weber B, et al. 1998. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62: 676–689.
- Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvhill JJ. 1989. Projecting individualized probabilities of developing breast cancer for white females who are examined annually. J Natl Cancer Inst 81: 1879–1886.
- Gehan EA. 1965. A generalized Wilcoxon test for comparing arbitrarily single censored samples. Biometrika 52: 203–223.
- Heiman GA, Hodge SE, Wickramaratne P, Hsu H. 1996. Age-at-interview bias in anticipation studies: computer simulations and an example with panic disorder. Psychiat Genet 6: 61–66.
- Horwitz M, Goode EL, Jarvik GP. 1996. Anticipation in familial leukemia. Am J Hum Genet 59: 990–998.
- Hsu L, Zhao LP. 1996. Assessing familial aggregation of age-of-onset using estimating equations: with application to breast cancer. Am J Hum Genet 58: 1057–1071.
- Hsu L, Zhao LP. 1998. Comparing failure times distributions for correlated data. Technical report. Seattle: Fred Hutchinson Cancer Research Center.
- Huang J, Vieland V. 1997. A new statistical test for age-of-onset anticipation, application to Bipolar Disorder. Genet Epidemiol 14: 1091–1096.
10.1002/(SICI)1098-2272(1997)14:6<1091::AID-GEPI88>3.0.CO;2-C CAS PubMed Web of Science® Google Scholar
- Hunter AG, Jacob P, O’Hoy K, MacDonald I, Mettler G, Tsilfidis C, Horneluk RG. 1993. Decrease in the size of the myotonic dystrophy CTG repeat during transmission from parent to child: implications for genetic counseling and genetic anticipation. Am J Med Genet 45: 401–407.
- Kaaks R. 1996. The epidemiology of diet and colorectal cancer: review and perspectives for future researches using biological markers. Ann Ist Super Sanita 32: 111–121.
- Kalbfleish JD, Prentice RL. 1980. The statistical analysis of failure time data. New York: John Wiley & Sons.
- Lindblom A. 1995. Familial breast cancer and genes involved in breast carcinogenesis. Breast Cancer Res Treat 34: 171–183.
- Loyd JE, Butler MG, Foroud TM, Conneally PM, Phillips JA, Newman JH. 1995. Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension. Am J Respir Crit Care Med 152: 93–97.
- Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, Neville C, et al. 1992. Myotonic dystrophy mutation: an unstable CTG repeat in the 3¢ untranslated region of the gene. Science 255: 1253–1255.
- Malone KE, Daling JR, Weiss NS, McKnight B, White E, Viogt LF. 1996. Family history and survival of young women with invasive breast carcinoma. Cancer 78: 1417–1425.
10.1002/(SICI)1097-0142(19961001)78:7<1417::AID-CNCR7>3.0.CO;2-H CAS PubMed Web of Science® Google Scholar
- Martin DC, Diehr P, Perrin EB, Koepsell TD. 1993. The effect of matching on the power of randomized community intervention studies. Stat Med 12: 329–338.
- McInnis MG, McMahon FJ, Chase GA, Simpson SG, Ross CA, Depaulo JR. 1993. Anticipation in bipolar affective disorder. Am J Hum Genet 53: 385–390.
- Miki Y, Swensen J, Shattuck-Eidens D, Futreal A, Harshman K, Tavtigian S, Liu Q, et al. 1994. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66–71.
- Miller BA, Ries LAG, Hankey BF, Kosary CL, Edwards BK, editors. 1992. Cancer Statistics Review: 1973–1989. Bethesda: National Cancer Institute. NIH Pub. No. 92–2789.
- Narod SA, Goldgar D, Cannon-Albright L, Weber B, Moslehi R, Ives E, Lenoir G, Lynch H. 1995. Risk modifies in carriers of BRCA1 mutations. Int J Cancer 64: 394–398.
- Paterson AD, Kennedy JL, Petronis A. 1996. Evidence for genetic anticipation in Non-Mendelian diseases [letter]. Am J Hum Genet 59: 264–268.
- Penrose LS. 1948. The problem of anticipation in pedigrees of dystrophia myotonica. Ann Eugenics 14: 125–132.
- Polito JM, Rees RC, Ghilds B, Mendeloff AI, Harris ML, Bayless TM. 1996. Preliminary evidence for genetic anticipation in Crohn’disease. LANCET 347: 798–800.
- Ranen NG, Stine OC, Abbott MH, Sherr M, Codori AM, Franz ML, Chao NI, et al. 1995. Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington’s disease. Am J Hum Genet 57: 593–602.
- Rebbeck TR, Couch FG, Kant J, Calzone K, DeShano M, Peng Y, Chen K, et al. 1996. Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2. Am J Hum Genet 59: 547–553.
- Rosner B, Colditz GA, Willet WC. 1994. Reproductive risk factors in a prospective study in breast cancer: the nurses’ health study. Am J Epidemiol 139: 819–835.
- Sanpei K, Takano H, Igarashi S, Sato T, Oyake M, Sasaki H, Wakisaka A, et al. 1996. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet 14: 277–284.
- Seitz S, Rohde K, Bender E, Nothnagel A, Kolble K, Schlag PM, Sherneck S. 1997. Strong indications for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families. Oncogene 14: 741–743.
- Serova OM, Mazoyer S, Puget N, Dubois Y, Tonin P, Shugart YY, Goldgar D, Marod SA, Lynch HT, Lenoir GM. 1997. Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? Am J Hum Genet 60: 486–495.
- Schalling M, Hudson TJ, Buetow KH, Housman DE. 1993. Direct detection of novel expanded trinucleotide repeats in the human genome. Nat Genet 4: 135–139.
- Sobol H, Birnbaum D, Eisinger F. 1994. Evidence for a third breast cancer susceptibility gene. Lancet 344: 1151–1152.
- Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, et al. 1996. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 13: 117–119.
- Tsai YY, Petersen GM, Booker SV, Bacon JA, Hamilton SR, Giardiello FM. 1997. Evidence against genetic anticipation in familial colorectal cancer. Genetic Epidemol 14: 435–436.
- Ursin G, Henderson BE, Haile RW, Pike MC, Zhou N, Diep A, Bernstein L. 1997. Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations than in other women? Cancer Res 57: 3678–3681.
- Warren ST, Ashley CT. 1995. Triplet repeat expansion mutations: the example of fragile X syndrome. Annu Rev Neurosci 18: 77–99.
- White E. 1987. Projected changes in breast cancer incidence due to the trend toward delayed childbearing. Pub Health Briefs 77: 495–497.
- White E, Lee CL, Kristal AR. 1990. Evaluation of the increase in breast cancer incidence in relation to mammography use. J Natl Cancer Inst 82: 1546–1552.
- White E, Malone KE, Weiss NS, Daling JR. 1994. Breast cancer among young U.S. women in relation to oral contraceptive use. J Natl Cancer Inst 86: 505–514.
- Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, et al. 1995. Identification of the breast cancer gene BRCA2. Nature 378: 789–791.